重组白细胞介素2体外折叠的实验研究

包涵体中的重组蛋白贩提后可以在变性状态下纯化,而纯化后的体外折叠（即复性）是基因工程下处理中的重要环节。荧光光谱研究表明,ＩＬ－２分子折叠过程中荧光强度逐渐减小,最大发射峰由３１６ｎｍ红移到３４８ｎｍ。以Ｔｒｐ残基的暴露程序反映分子的折叠状态,ＧＭ－ＣＳＦ在折叠过程中的荧光强度有类似变化,凝胶排阻ＨＰＬＣ可以检测折叠过程中的聚合体,而反相ＨＰＬＣ可以将ＩＬ－２分成三个相互独立的异构体色谱峰,据此可     

人重组IL6／IL2融合蛋白的变化,复性及纯化

经超声破碎,分离已表达ＣＨ９２５包涵体,较系统地研究变性剂浓度、融合蛋白浓度对蛋白折叠的影响,在还原型及氧化型谷胱复性条件下,成功地将融合蛋白ＣＨ９２５折叠成具有ＩＬ６及ＩＬ２双活性蛋白,ＩＬ６的比活为２．３×１０＾８Ｕ／ｍｇ,ＩＬ２比活为２．２×１０６Ｕ／ｍｇ。经阴离子交换,凝过滤层析,获得一定纯度的ＣＨ９２５,配合反相ＨＰＬＣ,洗脱收集蛋白峰,ＣＨ９２５纯度为９８％。     

伴侣分子纯化及其催化的重组蛋白质折叠反应

我们自Ｅ．ｃｏｌｉ细胞中纯化出ＧｒｏＥＬ和ＧｒｏＥＳ,对其有活性的分子状态和反应条件进行了探索,只有在等摩尔的ＧｒｏＥＬ和ＧｒｏＥＳ以及１ｍｍｏｌ／Ｌ ＡＴＰ和适当浓度的Ｋ＾＋存在时,才会有较高的催化折叠效率,它可使１ｍｇ／ｍｌ的ＩＬ－２的正确折叠率由３０％提高到５８％,使ＩＬ－２和ＧＭ－ＣＳＦ的比活性提高１倍以上,它提高重组蛋白质正确折叠率的关键是可以降低折叠过程中形成聚合体。     

伴侣分子（GroE）纯化及其催化的重组蛋白质折叠反应

我们自Ｅ．ｃｏｌｉ细胞中纯化出ＧｒｏＥＬ和ＧｒｏＥＳ,对其有活性的分子状态和反应条件进行了探索,结果表明,只有在等摩尔的ＧｒｏＥＬ和ＧｒｏＥＳ以及１ｍｍｏｌ／ＬＡＴＰ和适当浓度的Ｋ＋存在时;才会有较高的催化折叠效率,它可使ｌｍｇ／ｍｌ的ＩＬ－２的正确折叠率由３０％提高到５８％,使ＩＬ－２和ＧＭ－ＣＳＦ的比活性提高１倍以上。它提高重组蛋白质正确拆叠率的关键是可以降低折叠过程中形成聚合体。     

脯氨酰顺—反异构酶的纯化及对重组蛋白质折叠反应…

脯氨酰异构是蛋白质折叠反应的限速步骤之一,体内被脯氨酰顺－反异构酶（ＰＰＩ）所催化。为了研究ＰＰＩ在重组蛋白体外折叠复性中的作用,我们自猪肾脏中纯化了ＰＰＩ,并对重组蛋白的酶促折叠过程进行了探讨。结果表明,ＰＰＩ催化的重组蛋白的折叠率和比活性,ＰＰＩ催化的重组蛋白的折叠反应主要是提高了它们了折叠速率,而不增加正确折叠率的比活性。ＰＰＩ在很低的浓度下即有很高的催化活性。     

白细胞介素—2—绿脓杆菌外毒素融合蛋白的分高纯化及其复性研究

表达的白细胞介素－２－绿脓杆菌外毒素（ＩＬ－２－ＰＥ）融合蛋白以包含体形式存在于宿主菌中,为分离纯化表达产物提供了方便,但因需进行复性,也增加了后处理的难度．我们采用４ｍｏｌ／Ｌ尿素、０．５％ＴｒｉｔｏｎＸ－１００的１×ＰＢＳ洗涤包含体两遍,再经ＳｅｐｈａｃｒｙｌＳ－３００分子筛及ＤＥＡＥ－ＳｅｐｈａｒｏｓｅＦＦ阴离子交换柱层析后,获得的融合蛋白纯度可达９０％～９５％。此外,我们从ＧＳＳＧ浓度、Ｌ－精氨酸浓度、复性蛋白质的起始浓度、复性液的ｐＨ值、复性温度及复性时间等参数入手,系统地研究了融合蛋白的复性条件,探索到了ＩＬ－２－ＭＥ４０和ＩＬ－２－ＰＥ６６４Ｇｌｕ融合蛋白复性的最适条件。     

胆碱脱氢酶光谱性质的研究

胆碱脱氢酶（ＣＤＨ）蛋白质部分内源荧光发射峰在３３５ｎｍ,并不受底物的影响,但底物可改变辅基ＦＡＤ部分的内源荧光光谱。应用ＦＴＩＲ技术研究了增溶ＣＤＨ的二级结构,其结果如下：５３．４％α－螺旋,２４．５％β－片层,１３．９％３１０－螺旋及０．５％β－回折。在ＣＤＨ处于非底物结合状态时,分子内部结构表现为α－螺旋以及β－片层优势构象,呈现出球状蛋白样的空间结构特征。在与底物作用过程中,３１０－螺旋的比例逐渐上升至４２％左右,与此同时α－螺旋结构则降低到３５％。提示了底物诱导ＣＤＨ分子内部发生了蛋白分子的重新折叠。     

脯氨酰顺－反异构酶的纯化及对重组蛋白质折叠反应的催化性能

脯氨酰异构是蛋白质折叠反应的限速步骤之一,体内被脯氨酰顺－反异构酶(PPI)所催化．为了研究PPI在重组蛋白体外折叠复性中的作用,我们自猪肾脏中纯化了PPI,并对重组蛋白的酶促折叠过程进行了探讨．结果表明,PPI催化的重组蛋白的折叠反应主要是提高了它们的折叠速率,而不增加正确折叠率和比活性,PPI在很低的浓度下即有很高的催化活性．     

嗜热蓝藻层理鞭枝藻（Mastigocladus laminosus）藻胆体在解离过程中荧光发射光谱和光能传递的研究

研究了层理鞭枝藻藻胆体在不同浓度磷酸缓冲溶液中解离过程中荧光发射光谱的变化和光能传递。完整藻胆体的７７Ｋ荧光光谱中只有一个峰,位于６８５ｎｍ它是末端发射体（核心－膜连接多肽和别藻蓝蛋白－Ｂ）的荧光峰。部分解离藻胆体的荧光光谱的主峰位移至６５２ｎｍ：次峰位于６８５ｎｍ;６６０ｎｍ为一弱荧光发射肩。它们依次为Ｃ－藻蓝蛋白,末端发射体和别藻蓝蛋白的荧光。严重解离藻胆体的荧光主峰移６４４ｎｍ;次峰由６８５ｎｍ移至６８２ｎｍ;６６０ｎｍ荧光发射肩消失。这表明Ｃ－藻蓝蛋白所捕获的光能已不能传递给别藻蓝蛋白,但可传递给末端发射体洞时又表明Ｃ－藻蓝蛋白不仅与别藻蓝蛋白相连接而且还与末端发射体相连接。提出该藻胆体光能传递链如下：核心－膜连接多肽藻红蓝蛋白→Ｃ－藻蓝蛋白→别藻蓝蛋白别藻蓝蛋白－Ｂ     

螺旋藻（Spirulina platensis）藻胆体在解离过程中荧光发射光谱和光能传递的研究

对螺旋藻（Ｓｐｉｒｕｌｉｎａｐｌａｔｅｎｓｉｓ）藻胆体在室温和７７Ｋ处于不同浓度磷缓冲溶液和不同解离时间的荧光发射光谱进行了研究。藻胆体在０．９ｍｏｌ／Ｌ磷酸缓冲溶液中,由于没有发生解离,光能传递效率高,在７７Ｋ荧光发射光谱中只有一个峰,位于６８７ｎｍ,属于别藻蓝蛋白－Ｂ。当藻胆体悬浮在０．３ｍｏｌ／Ｌ磷酸缓冲溶液中１分钟,７７Ｋ荧光光谱的主峰出现在６８４ｎｍ．又出现６５５ｎｍ和６６６ｎｍ荧光峰,它们依次属子Ｃ－藻蓝蛋白和别藻蓝蛋白。在２小时;６５５ｎｍ荧先峰成为主峰,６８４ｎｍ荧光峰为次峰,６６６ｎｍ荧光肩消失。这表明Ｃ－藻蓝蛋白所捕获的先能已不能传递给别藻蓝蛋白,但能传给别藻蓝蛋白－Ｂ。我们提出在螺旋藻藻胆体中存在两类Ｃ－藻蓝蛋白,一是与别藻蓝蛋白相连接,另一是与别藻蓝蛋白－Ｂ相连接。     

Non-chromatographic strategies for protein refolding

Overexpression of recombinant proteins in bacterial systems (such as E. coli) often leads to formation of inactive and insoluble ' inclusion bodies' . Protein refolding refers to folding back the proteins after solubilizing/unfolding the misfolded proteins of the inclusion bodies. Protein aggregation, a concentration dependent phenomenon, competes with refolding pathway. The refolding strategies largely aim at reducing aggregation and/or promoting correct folding. This review focuses on non-chromatographic strategies for refolding like dilution, precipitation, three phase partitioning and macro-(affinity ligand) facilitated three phase partitioning. The nanomaterials which disperse well in aqueous buffers are also discussed in the context of facilitating protein refolding. Apart from general results with these methods, the review also covers the use of non-chromatographic methods in protein refolding in the patented literature beyond 2000. The patented literature generally describes use of cocktail of additives which results in increase in refolding yield. Such additives include low concentration of chaotropic agents, redox systems, ions like SO4(2-) and Cl-, amines, carboxylic acids and surfactants. Some novel approaches like use of a "pressure window" or ionic liquids for refolding and immobilized diselenide compounds for ensuring correct -S-S- bonds pairing have also been discussed in various patents. In most of the patented literature, focus naturally has been on refolding in case of pharmaceutical proteins.     

Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta

A point mutation, lysine 97 --> isoleucine (K97I), in a surface loop in the beta-sheet protein interleukin 1beta (IL-1beta), exhibits increased levels of inclusion body (IB) formation relative to the wild-type protein (WT) when expressed in Escherichia coli. Despite the common observation that less stable proteins are often found in IBs, K97I is more stable than WT. We examined the folding pathway of the mutant and wild-type proteins at pH 6.5 and 25 degrees C with manual-mixing and stopped-flow optical spectroscopy to determine whether changes in the properties of transiently populated species in vitro correlate with the observation of increased aggregation in vivo. The refolding reactions of the WT and K97I proteins are both described by three exponential processes. Two exponential processes characterize fast events (0.1-1.0 s) in folding while the third exponential process correlates with a slow (70 s) single pathway to and from the native state. The K97I replacement affects the earlier steps in the refolding pathway. Aggregation, absent in the WT refolding reaction, occurs in K97I above a critical protein concentration of 18 microM. This observation is consistent with an initial nucleation step mediating protein aggregation. Stopped-flow kinetic studies of the K97I aggregation process demonstrate that K97I aggregates most rapidly during the earliest refolding times, when unfolded protein conformers remain highly populated and the concentration of folding intermediates is low. Folding and aggregation studies together support a model in which the formation of stable folding intermediates afford protection against further K97I aggregation.     

Mechanisms for quality control of misfolded transmembrane proteins

To prevent the accumulation of misfolded and aggregated proteins, the cell has developed a complex network of cellular quality control (QC) systems to recognize misfolded proteins and facilitate their refolding or degradation. The cell faces numerous obstacles when performing quality control on transmembrane proteins. Transmembrane proteins have domains on both sides of a membrane and QC systems in distinct compartments must coordinate to monitor the folding status of the protein. Additionally, transmembrane domains can have very complex organization and QC systems must be able to monitor the assembly of transmembrane domains in the membrane. In this review, we will discuss the QC systems involved in repair and degradation of misfolded transmembrane proteins. Also, we will elaborate on the factors that recognize folding defects of transmembrane domains and what happens when misfolded transmembrane proteins escape QC and aggregate. This article is part of a Special Issue entitled: Protein Folding in Membranes.     

Measurements of label free protein concentration and conformational changes using a microfluidic UV-LED method

This paper presents a microchip-based system for measuring concentrations and dynamic conformational changes in proteins without any use of extrinsic fluorescent labeling. The microchannel flow of protein molecules was integrated with an ultraviolet light-emitting diode (UV-LED, lambda ex = 295 nm) and a photodetector (lambda em = 330 nm). The intrinsic fluorescence shift, arising from selectively exciting aromatic amino acid tryptophan (Trp), was monitored to quantify refolding pathways by dynamically varying the concentration of the chemical denaturant, urea. Short diffusion distances in the microchannel result in rapid equilibrium between protein and titrating solutions. Dilutions on the chip were tightly regulated using pressure controls, rather than syringe-based flow, as verified with extensive on-chip tracer dye controls. The concentrations of proteins were first measured using the UV-LED microfluidic platform, and the data showed detection limits down to 72, 128, and 250 nM for tryptophan, bovine serum albumin (BSA), and bovine carbonic anhydrase (BCA), respectively. To validate the protein assay method, folding transition experiments were performed using a well-characterized protein, BSA. The microchip protein refolding transitions using intrinsic fluorescence were well-correlated with conventional fluorometer experiments. The microfluidic platform facilitates refolding studies to identify rapidly the optimal folding strategy for a protein using small quantities of material. The technique offers a real alternative to bulky microfluidic systems consisting of large and expensive laser-based designs.     

具有分子伴侣功能的抗体

蛋白质的折叠问题一直是生物学研究的前沿之一，蛋白质稳态平衡的破坏与衰老及很多神经退行性疾病的发病机理密切相关，而蛋白质的正确折叠与蛋白质稳态在很大程度上取决于分子伴侣参与构建的复杂网络。许多研究表明，抗体可以作为分子伴侣促进蛋白质的正确折叠，并阻止蛋白质的异常聚集，抗体所具有的严格底物特异性使其具备了治疗特定蛋白质折叠病、帮助包涵体复性等应用潜力。本文简要介绍了分子伴侣的研究进展，详细阐述了具有分子伴侣功能的抗体及单链抗体的研究进展，最后重点讨论了可抑制蛋白质聚集的抗体的研究近况。     

Ion-exchange resins greatly facilitate refolding of like-charged proteins at high concentrations

Protein refolding is a crucial step for the production of therapeutic proteins expressed in bacteria as inclusion bodies. In vitro protein refolding is severely impeded by the aggregation of folding intermediates during the folding process, so inhibition of the aggregation is the most effective approach to high‐efficiency protein refolding. We have herein found that electrostatic repulsion between like‐charged protein and ion exchange gel beads can greatly suppress the aggregation of folding intermediates, leading to the significant increase of native protein recovery. This finding is extensively demonstrated with three different proteins and four kinds of ion‐exchange resins when the protein and ion‐exchange gel are either positively or negatively charged at the refolding conditions. It is remarkable that the enhancing effect is significant at very high protein concentrations, such as 4 mg/mL lysozyme (positively charged) and 2 mg/mL bovine serum albumin (negatively charged). Moreover, the folding kinetics is not compromised by the presence of the resins, so fast protein refolding is realized at high protein concentrations. It was not realistic by any other approaches. The working mechanism of the like‐charged resin is considered due to the charge repulsion that could induce oriented alignment of protein molecules near the charged surface, leading to the inhibition of protein aggregation. The molecular crowding effect induced by the charge repulsion may also contribute to accelerating protein folding. The refolding method with like‐charged ion exchangers is simple to perform, and the key material is easy to separate for recycling. Moreover, because ion exchangers can work as adsorbents of oppositely charged impurities, an operation of simultaneous protein refolding and purification is possible. All the characters are desirable for preparative refolding of therapeutic proteins expressed in bacteria as inclusion bodies. Bioeng. 2011; 108:1068–1077. © 2010 Wiley Periodicals, Inc.     

The interaction of the GroEL chaperone with early kinetic intermediates of renaturing proteins inhibits the formation of their native structure

The main function of the chaperone GroEL is to prevent nonspecific association of nonnative protein chains and provide their correct folding. In the present work, the renaturation kinetics of three globular proteins (human alpha-lactalbumin, bovine carbonic anhydrase, and yeast phosphoglycerate kinase) in the presence of different molar excess of GroEL (up to 10-fold) was studied. It was shown that the formation of the native structure during the refolding of these proteins is retarded with an increase in GroEL molar excess due to the interaction of kinetic protein intermediates with the chaperone. Mg(2+)-ATP and Mg(2+)-ADP weaken this interaction and decrease the retarding effect of GroEL on the protein refolding kinetics. The theoretical modeling of protein folding in the presence of GroEL showed that the experimentally observed linear increase in the protein refolding half-time with increasing molar excess of GroEL must occur only when the protein adopts its native structure outside of GroEL (i.e. in the free state), while the refolding of the protein in the complex with GroEL is inhibited. The dissociation constants of GroEL complexed with the kinetic intermediates of the proteins studied were evaluated, and a simple mechanism of the functioning of GroEL as a molecular chaperone was proposed.     

Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support

The factors defining the correct folding and stability of integral membrane proteins are poorly understood. Folding of only a few select membrane proteins has been scrutinised, leaving considerable deficiencies in knowledge for large protein families, such as G protein coupled receptors (GPCRs). Complete reversible folding, which is problematic for any membrane protein, has eluded this dominant receptor family. Moreover, attempts to recover receptors from denatured states are inefficient, yielding at best 40–70% functional protein. We present a method for the reversible unfolding of an archetypal family member, the β₁-adrenergic receptor, and attain 100% recovery of the folded, functional state, in terms of ligand binding, compared to receptor which has not been subject to any unfolding and retains its original, folded structure. We exploit refolding on a solid support, which could avoid unwanted interactions and aggregation that occur in bulk solution. We determine the changes in structure and function upon unfolding and refolding. Additionally, we employ a method that is relatively new to membrane protein folding; pulse proteolysis. Complete refolding of β₁-adrenergic receptor occurs in n-decyl-β-D-maltoside (DM) micelles from a urea-denatured state, as shown by regain of its original helical structure, ligand binding and protein fluorescence. The successful refolding strategy on a solid support offers a defined method for the controlled refolding and recovery of functional GPCRs and other membrane proteins that suffer from instability and irreversible denaturation once isolated from their native membranes.